MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia
British Journal of Haematology · 2026-07 · 209 (1) · 16-27
DOI: 10.1111/bjh.70485 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 15.04.2026. Verfasst von Zhenyu Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: MicroRNAs, Purpura, Thrombocytopenic, Idiopathic, Megakaryocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Swedish government funds for clinical research (ALF), Alfred Österlunds Stiftelse.
Abstract (Originalsprache)
Immune thrombocytopenia (ITP) is a complex autoimmune disorder characterized by accelerated destruction of peripheral platelets and impaired megakaryopoiesis. While the cellular effectors, dysregulated T cells, hyperactive B cells and phagocytic macrophages are well characterized, the upstream epigenetic mechanisms orchestrating this multicellular immune network remain largely elusive. This review explores the hypothesis that microRNAs (miRNAs) may serve as critical architects of immune dysregulation and bone marrow failure in ITP. We evaluate the clinical utility of circulating miRNAs as non‐invasive biomarkers for diagnosis, risk stratification and predicting response to steroid and thrombopoietin receptor agonists therapies. Finally, we address current translational difficulties, such as data fragmentation and pre‐analytical variables. We propose a roadmap for integrating functional validation with multi‐omics, utilizing miRNA‐based approaches to facilitate and advance precision medicine in ITP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
- Center for Laboratory Medicine, Østfold Hospital Trust, Grålum, Norway.
- Multidisciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital, Lørenskog, Norway.
- Department of Research, Østfold Hospital Trust, Grålum, Norway.
- Department of Medicine, Østfold Hospital Trust, Grålum, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Johan Rebetz, Rick Kapur, John W Semple
Förderung
- Vetenskapsrådet
- Swedish government funds for clinical research (ALF)
- Alfred Österlunds Stiftelse
Zitieren
APA
Liu, Z., Rebetz, J., Garabet, L., Ghanima, W., Xu, P., Wadenvik, H., Provan, D., Kapur, R., & Semple, J. W. (2026). MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia. British Journal of Haematology, 209(1), 16-27. https://doi.org/10.1111/bjh.70485
Vancouver
Liu Z, Rebetz J, Garabet L, Ghanima W, Xu P, Wadenvik H, et al. MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia. British Journal of Haematology. 2026;209(1):16-27. doi:10.1111/bjh.70485
BibTeX
@article{Liu2026,
author = {Liu, Zhenyu and Rebetz, Johan and Garabet, Lamya and Ghanima, Waleed and Xu, Peipei and Wadenvik, Hans and Provan, Drew and Kapur, Rick and Semple, John W},
title = {MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {1},
pages = {16--27},
doi = {10.1111/bjh.70485}
}
EUVIMED